Daiwa Securities Group’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $18K | Buy |
177
+17
| +11% | +$1.73K | ﹤0.01% | 1098 |
|
|
2025
Q1 | $19K | Hold |
160
| – | – | ﹤0.01% | 1069 |
|
|
2024
Q4 | $14K | Sell |
160
-15
| -9% | -$1.31K | ﹤0.01% | 1100 |
|
|
2024
Q3 | $16K | Hold |
175
| – | – | ﹤0.01% | 1107 |
|
|
2024
Q2 | $14K | Hold |
175
| – | – | ﹤0.01% | 1140 |
|
|
2024
Q1 | $14K | Hold |
175
| – | – | ﹤0.01% | 1143 |
|
|
2023
Q4 | $14K | Hold |
175
| – | – | ﹤0.01% | 1140 |
|
|
2023
Q3 | $12K | Hold |
175
| – | – | ﹤0.01% | 1111 |
|
|
2023
Q2 | $13K | Hold |
175
| – | – | ﹤0.01% | 1117 |
|
|
2023
Q1 | $11K | Hold |
175
| – | – | ﹤0.01% | 1095 |
|
|
2022
Q4 | $13K | Buy |
175
+46
| +36% | +$3.42K | ﹤0.01% | 1093 |
|
|
2022
Q3 | $6K | Hold |
129
| – | – | ﹤0.01% | 1146 |
|
|
2022
Q2 | $5K | Hold |
129
| – | – | ﹤0.01% | 1159 |
|
|
2022
Q1 | $5K | Hold |
129
| – | – | ﹤0.01% | 1165 |
|
|
2021
Q4 | $5K | Hold |
129
| – | – | ﹤0.01% | 1184 |
|
|
2021
Q3 | $4K | Buy |
129
+59
| +84% | +$1.83K | ﹤0.01% | 1184 |
|
|
2021
Q2 | $5K | Hold |
70
| – | – | ﹤0.01% | 1064 |
|
|
2021
Q1 | $4K | Hold |
70
| – | – | ﹤0.01% | 1085 |
|
|
2020
Q4 | $6K | Sell |
70
-139
| -67% | -$11.9K | ﹤0.01% | 1043 |
|
|
2020
Q3 | $15K | Buy |
209
+14
| +7% | +$1.01K | ﹤0.01% | 1007 |
|
|
2020
Q2 | $11K | Hold |
195
| – | – | ﹤0.01% | 1049 |
|
|
2020
Q1 | $11K | Hold |
195
| – | – | ﹤0.01% | 1044 |
|
|
2019
Q4 | $20K | Buy |
+195
| New | +$20K | ﹤0.01% | 1004 |
|